This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Are you interested in a career in competitiveintelligence? The industry is constantly growing as organisations recognise the value of mapping the competitivelandscape, and quantifying the threats and opportunities presented by rivals. Aqute Intelligence is always looking for new analysts to join our global team.
A director of competitiveintelligence role is open at Moderna , one of the pharmaceutical companies that has developed a vaccine for COVID-19. In the role, the selected hire will be tasked with providing competitive and strategic insights to monitor the competitivelandscape. ArchIntel™ -.
Pharma faces an increasingly competitivelandscape, an expensive but mission-critical process, and a high level of uncertainty––and there is only one way out: information. There have been some drastic changes in the pharmaceutical industry over the past two decades. Enter Intelligence Connector. But it can be done.
Our report details this shift across various sectors, including Banking and Finance, Consumer Products, Food and Beverage, Healthcare and Pharmaceutical, Media and Entertainment, Retail, Technology, Transportation, and Travel and Hospitality. On the contrary, it indicates that many brands bring their consumer insight efforts in-house.
Without a doubt, each company in the crucial sector will press their competitiveintelligence executives for the insights needed to enhance competitiveness amid uncertain times. Kinzer also directs global situational assessments, large-scale market modeling and competitivelandscape research, according to her LinkedIn profile.
Contify, an AI-enabled market and competitiveintelligence solutions provider, announced today that it has successfully deployed its platform to generate customized daily competitiveintelligence reports for a leading pharma company focused on the development of novel drugs to treat rare diseases. About Contify.
This research often includes assessing the financial performance, market potential, competitivelandscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.
Being in charge of drug production and distribution, pharmaceutical companies have a unique and immense responsibility. And pharmaceutical analytics can help brands stand out amid growing competition to unlock previously hidden opportunities. Data analytics is how to unlock and apply that wealth in everyday decision-making.
They often believe they “know everything there is to know” about their market and competitivelandscape. The analyst should be drawing on a variety of both primary and secondary intelligence. Cultural intelligence (C) From SWOT to TOWS. How are salespeople managed if they reject the findings of sales intelligence?
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Monitor key activity within the landscape. Our initial analysis disclosed some emerging trends in IO modalities and trial locations. Obtain details on competitor clinical trial locations.
Business Problem: A pharmaceutical company wants to predict the sales of a drug for the next two months, based on drug sales data from the past 12 months. How Can the ARIMA Forecasting Method Be Used for Enterprise Analysis? Data Pattern: Input data exhibits non-stationarity and cyclical pattern. About Smarten.
Competitor monitoring transcends industries and equips every kind of business—from startups to global corporations—with the intelligence they need to navigate complex markets and outmaneuver their competition. To cut through the noise and get straight to the information that matters, you need a comprehensive competitor monitoring tool.
AlphaSense, a leading AI-based market intelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. A fully realized M&A research strategy incorporates the power of Expert Insights and an all-in-one market intelligence platform to maximize return on investment (ROI).
This past September, Danish pharmaceutical company Novo Nordisk surpassed LVMH to become the most valuable listed company in Europe due to a surge in demand for its highly efficient diabetes and weight-loss medications, Ozempic and Wegovy. AlphaSense provides this and more.
Since the inception of the COVID-19 pandemic , artificial intelligence (AI) has ushered in a transformative era in drug discovery , development, and healthcare. Massive Data Analysis It’s clear that the pharmaceutical industry is increasingly in need of handling and interpreting expansive datasets efficiently and accurately.
Some are equipped with artificial intelligence capabilities that enable you to maximize and streamline your research, while others are more traditional in their approach. The Value: AlphaSense is an AI-powered search engine for market intelligence.
By Benjamin Gilad In two previous posts I featured the relevance of Porters insights to CompetitiveIntelligence professionals struggling with ad hoc information requests and few or no frameworks to think about the big picture. I wonder- do these attitudes affect European CEOs use of competitiveintelligence as well?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content